menu search

RVTY / Revvity: New Name - But New Investment Outlook? Reiterate Buy

Revvity: New Name - But New Investment Outlook? Reiterate Buy
Revvity, formerly PerkinElmer, has changed its name and made several updates to its investment outlook. It now has ~$2Bn to put to work following the sale of recent business units. I am still eyeing a price range of $137-145 following the latest investment updates. Read More
Posted: Jul 18 2023, 04:00
Author Name: Seeking Alpha
Views: 110128

RVTY News  

Why Revvity Stock Plunged Today

By The Motley Fool
October 30, 2023

Why Revvity Stock Plunged Today

Revvity announced weaker-than-expected third-quarter results and lowered its full-year outlook. CEO Prahlad Singh blamed today's "increasingly challen more_horizontal

Revvity (RVTY) Misses on Q3 Earnings, Lowers '23 EPS View

By Zacks Investment Research
October 30, 2023

Revvity (RVTY) Misses on Q3 Earnings, Lowers '23 EPS View

Revvity's (RVTY) third-quarter results reflect the impact of increased market uncertainty. The company's earnings and sales miss their respective esti more_horizontal

Revvity tumbles on 3Q earnings miss; revised guidance in “increasingly challenging” environment

By Proactive Investors
October 30, 2023

Revvity tumbles on 3Q earnings miss; revised guidance in “increasingly challenging” environment

Revvity Inc posted third-quarter revenue and earnings that fell short of market expectations and lowered its full-year guidance in what it described a more_horizontal

Revvity (RVTY) Misses Q3 Earnings and Revenue Estimates

By Zacks Investment Research
October 30, 2023

Revvity (RVTY) Misses Q3 Earnings and Revenue Estimates

Revvity (RVTY) came out with quarterly earnings of $1.18 per share, missing the Zacks Consensus Estimate of $1.19 per share. This compares to earnings more_horizontal

Revvity cuts annual forecast on weak demand for diagnostics, contract research

By Reuters
October 30, 2023

Revvity cuts annual forecast on weak demand for diagnostics, contract research

Revvity Inc cut its full-year sales and revenue forecasts after missing Wall Street estimates for third-quarter results, hurt by weak demand for its s more_horizontal

Revvity's (RVTY) New Tie-Up to Boost NGS Research Workflow

By Zacks Investment Research
October 19, 2023

Revvity's (RVTY) New Tie-Up to Boost NGS Research Workflow

Revvity's (RVTY) latest partnership is likely to address the workflow-related challenges faced by labs and democratize genomic sequencing. more_horizontal

Revvity (RVTY) Launches Three New Preclinical Research Systems

By Zacks Investment Research
September 6, 2023

Revvity (RVTY) Launches Three New Preclinical Research Systems

Revvity (RVTY) launches new preclinical imaging technologies for breakthrough discoveries. Learn how they can help advance research and boost Revvity' more_horizontal

Revvity, Inc. (RVTY) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 6, 2023

Revvity, Inc. (RVTY) Q2 2023 Earnings Call Transcript

Revvity, Inc. (NYSE:RVTY ) Q2 2023 Earnings Conference Call August 1, 2023 8:00 AM ET Company Participants Stephen Willoughby - Vice President of Inve more_horizontal


Search within

Pages Search Results: